JPRN-UMIN000024064
Completed
未知
Safety and efficacy of 3% diquafosol ophthalmic solution for soft contact lens-related dry eye. - Safety and efficacy of diquafosol ophthalmic solution for soft contact lens-related dry eye.
ConditionsDry eye
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Dry eye
- Sponsor
- Santen Pharmaceutical Co., Ltd.
- Enrollment
- 26
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
Refer to paper
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients have administration of eye drops for dry eye or steroid eye drops 14 days before start day of this study. Patient with an infection eye disease. Patient has a complication of an eye disease except dry eye. This complication is feared to discourage from evaluation of this study. Patients with allergy to the ingredients used in the present study.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Unknown
Phase 4
The Effect of 3% Diquafosol Ophthalmic Solution on Visual Display Terminal-associated Dry EyeDry Eye SyndromesComputer Vision SyndromeAsthenopiaNCT04668118Peking University Third Hospital68
Completed
Not Applicable
Clinical Effects and Safety of 3% Diquafosol After Cataract SurgeryDry Eye SyndromesNCT02608489Soonchunhyang University Hospital86
Completed
Not Applicable
Clinical effects of 3% diquafosol ophthalmic solution in dry eye disease patients using VDTDry EyeJPRN-UMIN000008990Tokyo Electric Power hospital100
Completed
Not Applicable
The efficacy of DIQUAS ophthalmic solution 3% for dry eye patients before cataract surgeryDry eyeJPRN-UMIN000029333Santen Pharmaceutical Co., Ltd.69
Not yet recruiting
Not Applicable
Effects of 3% diquafosol sodium ophthalmic solution on visual function in patient with dry eye wearing contact lens.JPRN-UMIN000010975Minamiaoyama Eye Clinic Tokyo20